🔍 Observations
Topline
- Revenue from operations surged 19.9% YoY (₹1,529,130M → ₹1,833,160M), with product sales as the primary engine at 20.2% growth.
- Q4 FY26 posted ₹524,625M — a 28.2% jump vs Q4 FY25 (₹409,201M), the strongest quarterly print of the year.
- Services and other operating revenues grew 9.6% and 25.8% YoY respectively — modest but consistent diversification.
Bottomline
- Full-year net profit held nearly flat at ₹146,795M vs ₹145,002M (+1.2% YoY) despite 19.9% revenue growth — a stark compression story.
- Q4 FY26 PAT (₹36,590M) declined 6.4% vs Q4 FY25 (₹39,111M), continuing the quarterly softening trend.
- Tax rate normalized sharply: effective rate rose to 23.2% in FY26 vs 26.1% in FY25 — deferred tax reversal in FY25 (₹12,369M) inflated last year’s base; current year deferred tax was only ₹1,192M outflow.
Margins
- EBITDA (PBT + D&A + Finance costs − Other income): FY26 = ₹191,185 + ₹67,417 + ₹2,387 − ₹43,572 = ₹217,417M; FY25 = ₹196,200 + ₹56,082 + ₹1,942 − ₹50,222 = ₹204,002M. EBITDA margin: FY26 = 11.86% vs FY25 = 13.34% on revenue from operations — 148 bps compression.
- Net profit margin contracted from 9.48% (FY25) to 8.01% (FY26) — driven by cost of materials consumed growing 27.9% vs revenue growth of 19.9%.
- Other income fell 13.2% YoY (₹50,222M → ₹43,572M), removing a tailwind that cushioned FY25 profits.
Growth Trajectory
- Revenue CAGR trajectory is healthy, but profit growth has decoupled — topline scaling without proportional bottomline flow-through signals rising cost intensity.
- Employee costs surged 28.8% YoY (₹70,260M → ₹90,497M), well ahead of revenue growth, suggesting workforce expansion ahead of productivity gains.
- Depreciation rose 20.2% YoY (₹56,082M → ₹67,417M), reflecting active capex cycle; near-term earnings will remain under amortisation pressure.
🧮 Profit & Loss Statement
🧮 Balance Sheet
🧮 Cash Flows Statement
🟢 Green Flags
- 28.2% Q4 revenue surge confirms strong end-market demand and likely market share gains — volume recovery momentum into FY27.
- Operating cash flow jumped 18.0% (₹161,800M → ₹190,999M), demonstrating that earnings quality remains intact despite reported profit stagnation.
- Trade payables rose ₹51,939M while trade receivables fell ₹12,360M — working capital management improved materially, funding operations without external debt.
- Zero net debt position maintained — lease liabilities of ₹1,025M are negligible; equity base expanded ₹109,164M to ₹1,071,563M organically.
- Capex sustained at ~₹101,227M on PPE/CWIP with CWIP growing to ₹94,062M — capacity being built for next growth phase without leveraging the balance sheet.
- Current investments nearly doubled (₹83,376M → ₹154,244M) alongside non-current financial investments up 5.8% — treasury corpus deepens financial resilience.
- EPS grew 1.2% (₹461.20 → ₹466.90) despite flat profits — share count unchanged, shareholder value not diluted.
🔴 Red Flags
- Material cost grew 27.9% vs revenue growth of 19.9% — input cost inflation is outpacing pricing power, structurally squeezing gross margins.
- Net profit margin compressed 147 bps (9.48% → 8.01%) — premium valuation multiples become harder to justify if this trend continues.
- Inventories ballooned 63.8% (₹69,132M → ₹113,206M) — aggressive stocking could indicate demand softness ahead or supply-chain pre-buying; watch FY27 Q1 closely.
- Other income declined 13.2% — investment yield compression or reduced corpus rotation reduces the profit buffer that flattered FY25 earnings.
- Employee costs +28.8% YoY with no corresponding margin improvement signals early-stage productivity gap in expanded workforce.
- PBT virtually flat at ₹191,185M vs ₹196,200M (−2.6%) despite nearly ₹304,030M more revenue — cost absorption is failing to leverage scale.
- Q4 FY26 PAT down 6.4% YoY — sequential and annual quarterly deterioration raises concern about FY27 earnings trajectory if cost pressures persist.
📊 Balance Sheet Analysis
- Asset-heavy, debt-free structure: Total equity at ₹1,071,563M funds 72% of the balance sheet; zero long-term financial debt — fortress-grade solvency.
- Liquidity adequate but skewed: Current ratio = ₹389,574M / ₹364,802M = 1.07x — functional but thin; cash equivalents of just ₹669M offset by ₹154,244M in liquid current investments.
- Fixed asset base expanding: Gross PPE + CWIP grew from ₹394,238M to ₹428,259M — capex discipline maintained with internal accruals funding expansion fully.
- Deferred tax liability rising (₹15,944M → ₹18,005M) — timing differences building up; not a concern at current leverage but bears monitoring with capex intensity.
💰 Cash Flow Analysis
- OCF of ₹190,999M comfortably covers capex of ₹103,976M (PPE + intangibles), yielding free cash flow of ~₹87,023M — strong capital generation.
- Net investing outflow of ₹147,335M largely reflects mutual fund churn (gross purchases ₹1,080,179M vs redemptions ₹1,019,686M) — headline looks large but is treasury rotation, not capex bleed.
- Dividend payout of ₹42,444M (vs ₹39,300M in FY25) — shareholder return policy remains progressive; payout funded entirely from OCF with headroom.
- Cash and equivalents declined to ₹669M, but ₹169,375M in combined current investments and other bank balances confirms liquidity is intact — cash balance alone is a misleading signal here.
💡 Investment Outlook
Maruti’s topline momentum is real — 20% revenue growth and record Q4 sales confirm volume and pricing execution — but the profit engine is running hotter without delivering more.
Material cost inflation and employee cost expansion are compressing margins faster than scale can offset, making FY27 earnings trajectory the critical variable to watch.
The balance sheet remains exceptional — no debt, self-funded capex, and a growing treasury — providing a structural floor to valuations.
Investors should focus on whether FY27 H1 shows cost stabilisation and inventory normalisation before re-rating the stock on growth multiples alone.
Disclaimer: This post features ChartAlert-AI-generated financial content which may contain inaccuracies or errors. This commentary is strictly for informational purposes and does not constitute a recommendation to buy or sell any security. Investors are responsible for performing their own due diligence; always consult with a licensed financial advisor before making investment decisions.
Beyond the Price Action: Fundamental Analysis is Coming to ChartAlert
ChartAlert is evolving into integrated research with a future update that will embed fundamental data into your workflow. Alongside technical analysis, the new release will allow access to financial spreadsheets, quarterly results review, earnings call transcripts, and valuation tools, connecting price action with corporate performance for smarter, data‑driven decisions.